Biopharmaceutical News and Research

RSS
Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer's

Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer's

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides

PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Kite collaborates with Gadeta to develop novel gamma delta TCR therapies for various cancers

Kite collaborates with Gadeta to develop novel gamma delta TCR therapies for various cancers

Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints

Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints

NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology

NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras announces publication of Phase 2 results of two TB vaccines

Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome

Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

Sartorius Stedim Biotech and Penn State partner to advance teaching, research in biotechnology

Sartorius Stedim Biotech and Penn State partner to advance teaching, research in biotechnology

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

Cleara Biotech creates three public-private partnerships to discover and develop new therapeutics

Cleara Biotech creates three public-private partnerships to discover and develop new therapeutics

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix resubmits NDA for DEXTENZA

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

AbbVie and Calibr collaborate to develop T-cell therapies aimed at cancer

AbbVie and Calibr collaborate to develop T-cell therapies aimed at cancer

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Protein Data Bank at Rutgers impacts research, education and drug discovery

Protein Data Bank at Rutgers impacts research, education and drug discovery